WFDC2 and ovarian carcinoma: Human epididymis protein 4—a promising biomarker—has been commonly used in many malignant tumors, especially in ovarian cancer.[11,35,36] The sensitivity and specificity of HE4 was higher than that of cancer antigen 125 as a tumor marker for ovarian cancer diagnosis.